Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
Core EBITDA Margin

    Back to All Ratios
SOLARA ACTIVE PHARMA SCIENCES is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SOLARA ACTIVE PHARMA SCIENCES
Please provide your vote to see the results

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -7.389.276.3123.8719.63

What is the latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest Core EBITDA Margin ratio of SOLARA ACTIVE PHARMA SCIENCES is -7.38 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-7.38
Mar20239.27
Mar20226.31
Mar202123.87
Mar202019.63

How is Core EBITDA Margin of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years Core EBITDA Margin % Change
Mar2024 -7.38
Negative
Mar2023 9.27
46.91
Mar2022 6.31
-73.57
Mar2021 23.87
21.60
Mar2020 19.63 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare Core EBITDA Margin ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹3,245.5 Cr 8% 33.1% 6.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,580.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,069.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹119,919.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹115,310.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,402.0 Cr -2.6% -8.1% -4.9% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

8%

33.1%

6.9%

SENSEX

-1.4%

0.7%

2.4%


You may also like the below Video Courses